TWI350755B - New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid - Google Patents

New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Info

Publication number: TWI350755B
Authority: TW; Taiwan
Prior art keywords: nonan; diazabicyclo; cyclopropyl; dihydro; oxo
Prior art date: 2004-04-01

Application number

TW094110161A

Other languages

English (en)

Other versions

TW200602053A (en

Inventor

Hubert Rast

Iris Heep

Alfons Grunenberg

Werner Hallenbach

Jordi Benet-Buchholz

Original Assignee

Bayer Animal Health Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-01

Filing date

2005-03-31

Publication date

2011-10-21

2005-03-31 Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh

2006-01-16 Publication of TW200602053A publication Critical patent/TW200602053A/zh

2011-10-21 Application granted granted Critical

2011-10-21 Publication of TWI350755B publication Critical patent/TWI350755B/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

TW094110161A 2004-04-01 2005-03-31 New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid TWI350755B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004015981A DE102004015981A1 (de)	2004-04-01	2004-04-01	Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (2)

Publication Number	Publication Date
TW200602053A TW200602053A (en)	2006-01-16
TWI350755B true TWI350755B (en)	2011-10-21

Family

ID=34962324

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW094110161A TWI350755B (en)	2004-04-01	2005-03-31	New crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Country Status (31)

Country	Link
US (1)	US7977484B2 (zh)
EP (1)	EP1737859B1 (zh)
JP (1)	JP5190259B2 (zh)
KR (1)	KR101217678B1 (zh)
CN (1)	CN100591681C (zh)
AR (2)	AR048099A1 (zh)
AT (1)	ATE450536T1 (zh)
AU (1)	AU2005231918B2 (zh)
BR (1)	BRPI0509529B8 (zh)
CA (1)	CA2561635C (zh)
CY (2)	CY1109762T1 (zh)
DE (3)	DE102004015981A1 (zh)
DK (1)	DK1737859T3 (zh)
ES (1)	ES2335899T3 (zh)
GT (1)	GT200500043A (zh)
HR (1)	HRP20100097T1 (zh)
IL (1)	IL178353A (zh)
MY (1)	MY140998A (zh)
NO (1)	NO337279B1 (zh)
NZ (1)	NZ550226A (zh)
PE (1)	PE20060170A1 (zh)
PL (1)	PL1737859T3 (zh)
PT (1)	PT1737859E (zh)
RU (1)	RU2383543C2 (zh)
SI (1)	SI1737859T1 (zh)
SV (1)	SV2006002070A (zh)
TW (1)	TWI350755B (zh)
UA (1)	UA84329C2 (zh)
UY (1)	UY28828A1 (zh)
WO (1)	WO2005097789A1 (zh)
ZA (1)	ZA200608072B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006010642A1 (de) *	2006-03-08	2007-09-27	Bayer Healthcare Aktiengesellschaft	Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de)	2006-03-08	2007-09-13	Bayer Healthcare Aktiengesellschaft	Arzneimittel enthaltend Fluorchinolone
DE102007026550A1 (de) *	2007-06-08	2008-12-11	Bayer Healthcare Ag	Extrudate mit verbesserter Geschmacksmaskierung
ES2886088T3 (es)	2017-02-13	2021-12-16	Bayer Animal Health Gmbh	Composición líquida que contiene pradofloxacina
CN115710267A (zh) *	2022-11-30	2023-02-24	天津大学	一种普拉沙星水合物晶体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19546249A1 (de) *	1995-12-12	1997-06-19	Bayer Ag	Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
WO1997031001A1 (de)	1996-02-23	1997-08-28	Bayer Aktiengesellschaft	Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
DE19854356A1 (de)	1998-11-25	2000-05-31	Bayer Ag	Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de)	1998-11-25	2000-05-31	Bayer Ag	Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) *	1998-11-25	2000-05-31	Bayer Ag	Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de)	1999-02-26	2000-08-31	Bayer Ag	Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) *	1999-02-26	2000-08-31	Bayer Ag	Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
US6627646B2 (en) *	2001-07-17	2003-09-30	Sepracor Inc.	Norastemizole polymorphs

2004
- 2004-04-01 DE DE102004015981A patent/DE102004015981A1/de not_active Withdrawn
2005
- 2005-03-10 GT GT200500043A patent/GT200500043A/es unknown
- 2005-03-15 AR ARP050101004A patent/AR048099A1/es not_active Application Discontinuation
- 2005-03-19 CA CA2561635A patent/CA2561635C/en not_active Expired - Lifetime
- 2005-03-19 WO PCT/EP2005/002953 patent/WO2005097789A1/de not_active Ceased
- 2005-03-19 PL PL05716236T patent/PL1737859T3/pl unknown
- 2005-03-19 EP EP05716236A patent/EP1737859B1/de not_active Expired - Lifetime
- 2005-03-19 CN CN200580010668A patent/CN100591681C/zh not_active Expired - Lifetime
- 2005-03-19 DK DK05716236.4T patent/DK1737859T3/da active
- 2005-03-19 NZ NZ550226A patent/NZ550226A/en not_active IP Right Cessation
- 2005-03-19 UA UAA200611491A patent/UA84329C2/ru unknown
- 2005-03-19 SI SI200530913T patent/SI1737859T1/sl unknown
- 2005-03-19 JP JP2007505435A patent/JP5190259B2/ja not_active Expired - Lifetime
- 2005-03-19 RU RU2006138362/04A patent/RU2383543C2/ru active
- 2005-03-19 US US11/547,420 patent/US7977484B2/en active Active
- 2005-03-19 AT AT05716236T patent/ATE450536T1/de active
- 2005-03-19 AU AU2005231918A patent/AU2005231918B2/en not_active Expired
- 2005-03-19 HR HR20100097T patent/HRP20100097T1/hr unknown
- 2005-03-19 DE DE502005008620T patent/DE502005008620D1/de not_active Expired - Lifetime
- 2005-03-19 BR BRPI0509529A patent/BRPI0509529B8/pt active IP Right Grant
- 2005-03-19 ES ES05716236T patent/ES2335899T3/es not_active Expired - Lifetime
- 2005-03-19 PT PT05716236T patent/PT1737859E/pt unknown
- 2005-03-30 UY UY28828A patent/UY28828A1/es not_active Application Discontinuation
- 2005-03-30 MY MYPI20051428A patent/MY140998A/en unknown
- 2005-03-31 PE PE2005000369A patent/PE20060170A1/es not_active Application Discontinuation
- 2005-03-31 TW TW094110161A patent/TWI350755B/zh not_active IP Right Cessation
- 2005-04-01 SV SV2005002070A patent/SV2006002070A/es unknown
2006
- 2006-09-28 IL IL178353A patent/IL178353A/en active IP Right Grant
- 2006-09-28 ZA ZA2006/08072A patent/ZA200608072B/en unknown
- 2006-10-26 KR KR1020067022260A patent/KR101217678B1/ko not_active Expired - Lifetime
- 2006-10-31 NO NO20064988A patent/NO337279B1/no unknown
2010
- 2010-01-29 CY CY20101100090T patent/CY1109762T1/el unknown
2011
- 2011-10-11 DE DE201112100055 patent/DE122011100055I1/de active Pending
- 2011-10-11 CY CY2011018C patent/CY2011018I1/el unknown
2016
- 2016-06-28 AR ARP160101954A patent/AR105177A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL1737859T3 (pl)	2010-04-30
NZ550226A (en)	2009-11-27
IL178353A (en)	2011-08-31
JP5190259B2 (ja)	2013-04-24
KR20070014157A (ko)	2007-01-31
ZA200608072B (en)	2008-01-08
DE122011100055I1 (de)	2012-03-15
AR105177A2 (es)	2017-09-13
NO337279B1 (no)	2016-02-29
ATE450536T1 (de)	2009-12-15
DE502005008620D1 (de)	2010-01-14
BRPI0509529A (pt)	2007-09-18
GT200500043A (es)	2006-02-17
BRPI0509529B1 (pt)	2019-05-21
SI1737859T1 (sl)	2010-03-31
DE102004015981A1 (de)	2005-10-20
RU2006138362A (ru)	2008-05-10
CA2561635A1 (en)	2005-10-20
HRP20100097T1 (hr)	2010-04-30
EP1737859B1 (de)	2009-12-02
ES2335899T3 (es)	2010-04-06
US7977484B2 (en)	2011-07-12
AU2005231918B2 (en)	2011-05-12
KR101217678B1 (ko)	2013-01-02
BRPI0509529B8 (pt)	2021-05-25
PT1737859E (pt)	2010-02-03
EP1737859A1 (de)	2007-01-03
CA2561635C (en)	2012-10-16
TW200602053A (en)	2006-01-16
MY140998A (en)	2010-02-12
CN100591681C (zh)	2010-02-24
UY28828A1 (es)	2005-11-30
CN1938304A (zh)	2007-03-28
WO2005097789A1 (de)	2005-10-20
UA84329C2 (en)	2008-10-10
US20080125458A1 (en)	2008-05-29
CY2011018I1 (el)	2016-12-14
IL178353A0 (en)	2007-02-11
DK1737859T3 (da)	2010-04-06
AR048099A1 (es)	2006-03-29
CY1109762T1 (el)	2014-09-10
PE20060170A1 (es)	2006-04-13
RU2383543C2 (ru)	2010-03-10
NO20064988L (no)	2006-10-31
HK1104537A1 (zh)	2008-01-18
SV2006002070A (es)	2006-03-15
AU2005231918A1 (en)	2005-10-20
JP2007530614A (ja)	2007-11-01

Publication	Publication Date	Title
IL186881A0 (en)	2008-02-09	Pyrido [2, 3 - d] pyrimidines useful as hcv inhibitors, and methods for the preparation thereof
EG25765A (en)	2012-07-09	Pyrido [2,3-B] pyrazine derivatives useful as herbicidal compounds
IL175813A0 (en)	2006-10-05	PYRIDO [2,3-d] PYRIMIDINE-2,4-DIAMINES AS PDE 2 INHIBITORS
WO2003051362A3 (en)	2003-08-07	Polymorphs of clopidogrel hydrogensulfate
IL189276A0 (en)	2008-08-07	Novel crystalline form of a pyridazino [4,5-b] indole derivative
IL182800A0 (en)	2007-09-20	Formulations of[1,4]diazepino[6,7,1-ij]quinoline derivatives
IL183591A0 (en)	2007-09-20	Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
ZA201107412B (en)	2012-07-25	Methods for the preparation of [2-8,9-dioxo2,6-diazabicyclo[5.2.0]non-1(1)-en-2-yl)ethyl]phosphonic acid and precursors thereof
PT1650186E (pt)	2008-09-16	Novos derivados de ácidos dicarboxílicos
DE122011100055I1 (de)	2012-03-15	Neue kristalline form von 8-cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicycloi4.3.0 nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsaure.
DK2134712T3 (da)	2013-11-18	Aspartat af 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro(3, 4)oct-6-yl)-4-oxo-1,4-dihydro-(1,8) naphthyridin-3-karboxylsyre, fremgangsmåde til fremstilling af samme og antimikrobielt farmaceutisk sammensætning omfattende samme
IL190459A0 (en)	2008-11-03	Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation and their use as pharmaceuticals
WO2008140646A3 (en)	2009-05-28	Process for the synthesis of cmhtp and intermediates thereof
ZA200704709B (en)	2008-08-27	A process for the preparation of substantially pure 4-mino-1-isobutyl-1H-imidazo[4,5-c]-quinoline (imiquimod)
IL187441A0 (en)	2008-02-09	Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
WO2006134491A3 (en)	2007-05-10	New crystalline form of moxifloxacin hydrochloride and process for its preparation
IL180311A0 (en)	2007-06-03	Process for the preparation of 4,4-difluoro-3-oxobutanoic acid esters
ZA200409433B (en)	2005-07-14	Process for the preparation of carboxylic acid esters.
PT1805316E (pt)	2009-07-06	Processo para a preparação das formas enantioméricas de derivados de ácido cis-3-hidroxiciclo-hexanocarboxílico utilizando hidrolases
IL174189A0 (en)	2006-08-01	Process for preparing 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
NO20044629L (no)	2004-10-27	Fremgangsmate til fremstilling av sure salter av gemifloksasin.
ZA200507741B (en)	2008-08-27	Novel intermediate for the preparation of therapeutically active imidazopyridines
ZA200603113B (en)	2007-08-29	Process for the preparation of risperidone
WO2007053722A3 (en)	2007-06-28	Crystalline form of cefdinir cesium salt
HK1101174A (zh)	2007-10-12	5-芳基-1h-吡咯并[2,3-b]吡啶-3-甲酰胺或5-芳基-1h-吡咯并[2,3-b]吡啶-3-羧酸的新衍生物

Legal Events

Date	Code	Title	Description
2025-05-11	MK4A	Expiration of patent term of an invention patent